The antibacterial medicine sales in Germany are forecasted to remain stable between 2024 and 2028, with a constant value of 9.6 US Dollars Per Capita. Comparing with the actual figures from 2023, the data shows no variation in the per capita value of antibacterial medicine sales, indicating a flat trend over the five-year forecast period. The year-on-year variation remains at 0% between 2024 to 2028.
Future trends to watch for include potential market shifts due to emerging bacterial resistance, changes in healthcare policy, advancements in medicine formulations, and the impact of public health initiatives promoting reduced antibiotic usage. Monitoring these factors will be crucial for anticipating any deviation from the current stable trend.
